Prognostic biomarkers and surrogate end points in PSC

Liver Int. 2016 Dec;36(12):1748-1751. doi: 10.1111/liv.13216.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers*
  • Biomarkers, Tumor*
  • Humans
  • Prognosis

Substances

  • Biomarkers
  • Biomarkers, Tumor